Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer by Nikki L. Burdett, Madelynne O. Willis, Ahwan Pandey, Laura Twomey, Sara Alaei, Australian Ovarian Cancer Study Group, David D. L. Bowtell, Elizabeth L. Christie

Get full text

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei by Mei Sim Lung, Catherine A. Mitchell, Maria A. Doyle, Andrew C. Lynch, Kylie L. Gorringe, David D. L. Bowtell, Australian Ovarian Cancer Study Group, Ian G. Campbell, Alison H. Trainer

Get full text

Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. by Kylie L Gorringe, Joshy George, Michael S Anglesio, Manasa Ramakrishna, Dariush Etemadmoghadam, Prue Cowin, Anita Sridhar, Louise H Williams, Samantha E Boyle, Nozomu Yanaihara, Aikou Okamoto, Mitsuyoshi Urashima, Gordon K Smyth, Ian G Campbell, David D L Bowtell, Australian Ovarian Cancer Study

Get full text

Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. by Catherine Emmanuel, Natalie Gava, Catherine Kennedy, Rosemary L Balleine, Raghwa Sharma, Gerard Wain, Alison Brand, Russell Hogg, Dariush Etemadmoghadam, Joshy George, Australian Ovarian Cancer Study Group, Michael J Birrer, Christine L Clarke, Georgia Chenevix-Trench, David D L Bowtell, Paul R Harnett, Anna deFazio

Get full text

UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer by Brittney S. Harrington, Rahul Kamdar, Franklin Ning, Soumya Korrapati, Michael W. Caminear, Lidia F. Hernandez, Donna Butcher, Elijah F. Edmondson, Nadia Traficante, Joy Hendley, Australian Ovarian Cancer Study, Madeline Gough, Rebecca Rogers, Rohan Lourie, Jyoti Shetty, Bao Tran, Fathi Elloumi, Abdalla Abdelmaksoud, Madhu Lal Nag, Krystyna Mazan-Mamczarz, Carrie D. House, John D. Hooper, Christina M. Annunziata

Get full text

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance by Ksenija Nesic, John J. Krais, Yifan Wang, Cassandra J. Vandenberg, Pooja Patel, Kathy Q. Cai, Tanya Kwan, Elizabeth Lieschke, Gwo-Yaw Ho, Holly E. Barker, Justin Bedo, Silvia Casadei, Andrew Farrell, Marc Radke, Kristy Shield-Artin, Jocelyn S. Penington, Franziska Geissler, Elizabeth Kyran, Robert Betsch, Lijun Xu, Fan Zhang, Alexander Dobrovic, Inger Olesen, Rebecca Kristeleit, Amit Oza, Iain McNeish, Gayanie Ratnayake, Nadia Traficante, Australian Ovarian Cancer Study, Anna DeFazio, David D. L. Bowtell, Thomas C. Harding, Kevin Lin, Elizabeth M. Swisher, Olga Kondrashova, Clare L. Scott, Neil Johnson, Matthew J. Wakefield

Get full text